7Th Annual Neuroscience Innovation Forum 2024 | Sachs Associates Ltd | 7 January 2024 | Marines' Memorial Club, 609 Sutter St, San Francisco, CA 94102, USA

The forum, positioned at the beginning of JPM week, focuses on the latest developments across key areas of Neuroscience which are currently drawing widespread investor interest. The main programme for the 7th Annual NIF will feature high-level keynotes and panel discussions addressing the important advances in therapeutic, neurotech and diagnostics fields.

Why you should attend:
• Latest Trends in Pharma Dealmaking Panel
• Advances in the Treatment of Alzheimer's & Other Cognitive Disorders Panel
• New Approaches to Neuro Psychiatric Disorders Panel
• Exploring New Modalities for Rare & Orphan Neurological Diseases Panel
• Innovations in Digital Solutions for Brain Health: Enhancing Patient Outcomes Panel
• New Frontiers in Neuro Stimulation & Implants: Changing Patients’ Lives Panel
• Investor Roundtable

2022 Past Speakers

Dimitris Horiatis
Senior Manager, Innovation & Technology, Invest Hong Kong

Harry Tracy
President, NI Research Inc.

Peter Nara
Chief Scientific Officer, Keystone Bio, Inc.

Charles Fisher
Founder & CEO, Unlearn.AI, Inc.

Adam Bruce
Founder, Chairman & CEO, TikoMed AB

Antoine Papiernik
Chairman & Managing Partner, Sofinnova Partners

Armineh Ghazarian
Portfolio Manager, National Institute on Aging

Beth Shafer
VP, Head of R&D BD, Gastroenterology, Neuroscience, Drug Discovery Sciences & Externalizations, Center for External Innovation, Takeda Development Center Americas, Inc.

Brian Pepin
Founder & CEO, Rune Labs, Inc.

Bruce Leuchter
President & CEO, Neurvati Neurosciences, Inc.

Carlos Buesa
Founder & CEO, Oryzon Genomics, S.A.

Catherine Abbadie
Global Head S&E, Simcere Pharmaceutical Group

Céline Bouquet
Neuroscience, Ophthalmology & Rare Diseases Pharma Partnering Site Head Basel, F. Hoffmann-La Roche Ltd.

Charles Stacey
President & CEO, Cerecin Inc.

Cheryl Zimberlin
Investment Director, M Ventures

Christa Studzinski
Manager, Partnerships & Investor Relations, Ontario Brain Institute

Christian Thomsen
Global Head, CNS BD&L, Boehringer Ingelheim International GmbH

Clement Gautier
Senior Director, External Innovation, Ipsen

Daniel Lee
Managing Director, PJT Partners

Dave Miller
CSO, Unlearn.AI, Inc.

David Neustaedter
Venture Partner, Deerfield Management

David Stamler
CEO, Alterity Therapeutics

Diana Saraceni
Founding Partner, Panakès Partners SGR SpA

Dirk Landgraf
Vice President - The Dementia Discovery Fund, SV Health Investors LLP

Dmitrij Hristodorov
Partner, Forbion

Guy Seabrook
Vice President & Global Lead, Neuroscience External Innovation, Johnson & Johnson Innovation LLC

Nida Sen
Global Clinical Development Lead, Janssen Research & Development, LLC

James Cavuoto
Editor & Publisher, Neurotech Reports

Jay Olson
Managing Director & Senior Analyst, Oppenheimer & Co. Inc.

Jenny Barnett
CEO, Monument Therapeutics Limited

Jenny Laird
Vice President, Search & Evaluation - Neuroscience, Eli Lilly and Company

Jesús Martin-Garcia
CEO, GeNeuro SA

Jill Hopkins
SVP Global Drug Development Ophthalmology, Novartis AG

Joel Sandler
Principal, Lumanity

John Alam
Founder & CEO, EIP Pharma, Inc.

Julianna Sullivan
Associate Director, Research Alliances, The Michael J. Fox Foundation for Parkinson's Research

Julien Veys
CBO, Theranexus S.A.

Keld Jørgensen
Executive VP & CBO, H. Lundbeck A/S

Kerrie Brady
President & CEO, OcuTerra Therapeutics Inc.

Lisa Ricciardi
President & CEO, Cognition Therapeutics, Inc.

Luca Benatti
CEO, EryDel SpA

Luca Ravagnan
Co-Founder & CEO, WISE S.r.l.

Lynn Durham
Founder & CEO, STALICLA SA

Manuel López-Figueroa
Scientific Liaison, Pritzker Neuropsychiatric Disorders Research Consortium

Meredith Fisher
Partner, Mass General Brigham Ventures

Murali Gopalakrishnan
Global Head, Neuroscience Search & Evaluation, Corporate Strategy Office, AbbVie, Inc.

Paul Bresge
CEO, Ray Therapeutics

Peter Louwagie
BD&L Partnering Immunology Head, Novartis AG

Peter Thompson
General Partner, OrbiMed Advisors LLC

Rafiq Hasan
CEO, Complement Therapeutics Ltd

Riad Sherif
CEO, Oculis SA

Richard Godfrey
CEO, IRLAB Therapeutics AB

Ross O’Neill
Founder & CEO, Neuromod Devices

Sahil Kirpekar
CBO, atai Life Sciences N.V.

Stephanie Léouzon
Partner & Head of Europe, Torreya

Steve Dickman
CEO, CBT Advisors

Sumant Kulkarni
Managing Director, Biotechnology Equity Research, Canaccord Genuity LLC

Thomas Shrader
Managing Director & Healthcare Analyst, BTIG, LLC